Regulatory Spine Top Stories SpinaFX Medical receives FDA Investigational Device Exemption (IDE) for Triojection®, its Breakthrough, Minimally-Invasive, Image-Guided Lumbar Disc Treatment. byJosh SandbergJune 9, 2026
Recon Regulatory Top Stories Capitan Orthopedics, Inc. Announces Breakthrough Device Designation for its SupraSpacer™ Implant byJosh SandbergApril 30, 2026
Spine Top Stories Synergy Spine Solutions® Receives FDA Approval for its Synergy Disc®, Expanding Cervical Disc Replacement Options for U.S. Patients byNoah SimmonsFebruary 27, 2026
Regulatory Spine Top Stories FDA Grants PMA Approval to LimiFlex™ Dynamic Sagittal Tether byTim AllenFebruary 18, 2026
Regulatory Sports Medicine Organogenesis Announces Successful FDA Meeting and Plan to File BLA for ReNu® for Knee Osteoarthritis Pain byTim AllenDecember 15, 2025
Regulatory Spine Top Stories Companion Spine Announces FDA Premarket Approval (“PMA”) of the DIAM™ Spinal Stabilization System for the Treatment of Degenerative Disc Disease (“DDD”) byJosh SandbergDecember 15, 2025
Extremities Regulatory Inside information: Bioretec has been granted FDA Breakthrough Device Designation status for its RemeOs™ DrillPin byTim AllenDecember 15, 2025
Biologics Regulatory Spine BioRestorative Granted Type B Meeting with FDA to Discuss Accelerated BLA Approval Pathway for BRTX-100 in Chronic Lumbar Disc Disease byJosh SandbergNovember 17, 2025
Recon Regulatory Zimmer Biomet Announces FDA Breakthrough Designation for World’s First Iodine-Treated Total Hip Replacement System byTim AllenOctober 28, 2025
